Dolby Laboratories (DLB) Asset Writedowns and Impairment (2009 - 2026)

Dolby Laboratories (DLB) has 18 years of Asset Writedowns and Impairment data on file, last reported at $553000.0 in Q2 2026.

• Quarterly Asset Writedowns and Impairment fell 10.08% year-over-year to $553000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.1 million (up 51.26% YoY) and the FY2025 annual result came in at $2.4 million, up 207.89% from the prior year.
• Asset Writedowns and Impairment slipped to $553000.0 in Q2 2026, from $2.9 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $16.9 million in Q3 2023 to a low of -$2.1 million in Q4 2023.
• A 5-year average of $1.3 million and a median of $615000.0 in 2025 frame the typical range for Asset Writedowns and Impairment.
• The widest YoY moves for Asset Writedowns and Impairment: up 1132.34% in 2023, down 234.63% in 2023.
• Tracing DLB's Asset Writedowns and Impairment over 5 years: stood at -$1.0 million in 2022, then plunged by 103.98% to -$2.1 million in 2023, then jumped by 134.75% to $730000.0 in 2024, then grew by 8.49% to $792000.0 in 2025, then tumbled by 30.18% to $553000.0 in 2026.
• The last three Asset Writedowns and Impairment figures came in at $553000.0 (Q2 2026), $2.9 million (Q1 2026), and $792000.0 (Q4 2025), per Business Quant data.